Skip to search.
 TSX Up 0.11% TSX Ventures Down 0.30%

Hemispherx Biopharma, Inc. (HEB)

-NYSE MKT
0.18 Up 0.01(6.55%) Aug 23, 4:00PM EDT
Prev Close:0.17
Open:0.20
Bid:0.18 x 5000
Ask:0.22 x 10000
1y Target Est:0.96
Beta:-1.09215
Earnings Date:Nov 15 - Nov 21 (Est.)
Day's Range:0.18 - 0.22
52wk Range:0.06 - 0.22
Volume:7,928,816
Avg Vol (3m):1,166,010
Market Cap:44.51M
P/E (ttm):N/A
EPS (ttm):-0.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
HEBUp 6.55%44.51M
GILDUp 0.68%107.51B
MRKUp 0.05%175.81B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):402.12
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the Un... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback